Download Ashley Herring Marx, PharmD, BCPS

Survey
yes no Was this document useful for you?
   Thank you for your participation!

* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project

Document related concepts

Hygiene hypothesis wikipedia , lookup

Transmission (medicine) wikipedia , lookup

Infection wikipedia , lookup

Infection control wikipedia , lookup

Multiple sclerosis research wikipedia , lookup

Hospital-acquired infection wikipedia , lookup

Transcript
Ashley Herring Marx, PharmD, BCPS
CURRICULUM VITAE
February 2015
Work:
UNC Medical Center
101 Manning Dr
Chapel Hill, NC 27514
Home:
5512 Sutteridge Ct
Durham, NC 27713
[email protected]
EDUCATION
2006-2007
PGY2, Infectious Diseases
Wake Forest Baptist Health
Winston-Salem, NC
2004-2005
PGY1
Medical University of South Carolina
Charleston, SC
1999-2004
UNC Eshelman School of Pharmacy
Chapel Hill, NC
Doctor of Pharmacy with Honors and Distinction
1995-1999
University of North Carolina at Chapel Hill
Chapel Hill, NC
Bachelor of Science with Highest Distinction, Biology
PROFESSIONAL EXPERIENCE
2013-current
Clinical Pharmacy Specialist, Infectious Diseases
University of North Carolina Medical Center
Assistant Professor for Clinical Education
Division of Practice Advancement and Clinical Education
UNC Eshelman School of Pharmacy, Chapel Hill, NC
• Provide clinical pharmacy services in support of ID consultants
on general and immunocompromised host services, and on
infectious disease-focused medicine team.
• Additional hospital services: Anti-Infective Subcommittee
member; UNC Outpatient Parenteral Antimicrobial Therapy
(OPAT) program consultant pharmacist; Lead pharmacist for
Antimicrobial Stewardship Program; Coordinator, UNC Code
Sepsis Initiative.
• Coordinate infectious diseases pharmacotherapy module
(PHCY449) for pharmacy students.
• Lecturer, Infectious Diseases elective (DPET811).
• Provide clinical rotations for pharmacy students, PGY1, and PGY2
residents.
2011-2013
Clinical Assistant Professor, Department of Pharmacotherapy and
Outcomes Sciences
Virginia Commonwealth University School of Pharmacy
Richmond, VA
2009-2013
Clinical Pharmacy Specialist, Infectious Diseases
Inova Fairfax Hospital
Falls Church, VA
• Developed new antimicrobial stewardship program in mixed
teaching/community hospital environment.
• Provide daily surveillance and intervention support for the Inova
Fairfax Hospital antimicrobial stewardship program.
• Coordinated antimicrobial stewardship initiatives and formulary
management for 5-hospital health system.
• Developed and maintained a n t i m i c r o b i a l order sets and
decision-support tools for computerized physician order entry
systems (GECE, EpicCare).
• Provided clinical pharmacy services in support of staff
pharmacists and ID consultants.
• Developed competency modules for pharmacy department
employees regarding anti-infective therapies.
• Precepted infectious diseases rotations for PGY-1 residents and
Doctor of Pharmacy candidates.
• Co-chair of the Inova Health System Antimicrobial
Subcommittee.
• Served as pharmacy representative on Sepsis, Infection Control
and Prevention, and Surgical Care and Infection Prevention
Committees.
2007-2009
Clinical Pharmacist, Infectious Diseases
Emory University Hospital Midtown
Atlanta, GA
• Provided system-wide antimicrobial surveillance activities
including prospective audit and feedback to academic
and community prescribers.
• Coordinator of the Emory Healthcare Antimicrobial Usage
Committee (subcommittee of Pharmacy and
Therapeutics committee) including formulary
management, development and implementation of
antimicrobial policies.
• Provided pharmacotherapy services including kinetics
and anticoagulation monitoring, patient counseling, and
targeted medication histories for patients on ID consult
teams and other hospital units.
• Provided pharmacokinetic orientation to pharmacy staff
and PGY-1 residents.
• Precepted infectious diseases rotations for PGY-1
residents, medical residents, and Doctor of Pharmacy
candidates.
• Served as chair of PGY-1 Research Committee.
2004-2006
Clinical Pharmacist
Medical University Hospital
Charleston, SC
• Facilitated proper selection, distribution, administration, and
monitoring of medications for patients in the Heart and
Vascular Center and Coronary Care Unit.
• Provided therapeutic consults and patient counseling
services as requested.
• Assisted in training of new pharmacy staff and residents.
2005-2007
Pharmacist (PRN)
Walgreen’s Pharmacy
Charleston, SC and Winston-Salem, NC
2003
Research Assistant
University of North Carolina Eshelman School of Pharmacy
Chapel Hill, NC
Screened and consented patients for clinical studies of intestinal UDPglucuronosyltransferase enzyme activity. Participated in protocol writing
and revision. Prepared regulatory documents and IRB submissions for new
and ongoing clinical protocols. Assisted in adaptation of published HPLC
probe assay with new internal standards.
2000-2001
Laboratory Research Assistant
The Henry M. Jackson Foundation for the Advancement of Military
Medicine, United States Military HIV Research Program affiliate
Rockville, MD
Conducted basic research in support of Phase I trials of HIV vaccines.
Cultured autologous dendritic cells and conducted quality assurance
testing for human reinfusion protocol. Performed ELISA and ELISpot
immunoassays in support of HIV vaccine trials. Assisted in volunteer
recruitment and screening visits. Regulatory Affairs Specialist
Prepared IND updates for the FDA. Organized and maintained regulatory
records of ongoing and archived clinical trials. Published weekly progress
reports of ongoing clinical trials.
LICENSURE AND CERTIFICATION
2004-current
Pharmacist 18234, North Carolina Board of Pharmacy
2005-current
Board Certified Pharmacotherapy Specialist, American College of
Clinical Pharmacy
RESEARCH EXPERIENCE
2014-2015
Clinical evaluation of posaconazole therapeutic drug monitoring
comparing delayed release tablets and oral suspension formulations.
UNC Medical Center
Chapel Hill, NC
Faculty Advisor for PGY2 research project. PI: Jacqueline Isip, PharmD.
Co-investigators: Pearlie Chong, MD; Maurice Alexander, PharmD,
BCOP; Jill Bates, PharmD, BCOP; Anastasia Ivanova; Madison
Bushman, PharmD Candidate.
2014-2015
Use of proton-pump inhibitors and histamine type-2 antagonists among
patients with C. difficile associated diarrhea.
UNC Medical Center
Chapel Hill, NC
Faculty Advisor for Clinical Scholars Track student project. Coinvestigator, Harrison Lyle, PharmD Candidate.
2012-2013
Development of disease-state-specific antibiograms for outpatient
emergency department population.
Inova Fairfax Hospital
Falls Church, VA
Co-Investigators: Jessica Schnur, PharmD; Mona Shah, PharmD, BCPS
2011-2012
Appropriateness of initial therapy for community-acquired pneumonia
and healthcare-associated pneumonia in patients admitted through
the emergency department.
Inova Fairfax Hospital
Falls Church, VA
Co-Investigator: Jenna T. Smith, PharmD
2010-2012
Clinical outcomes associated with doripenem as initial empiric therapy
in febrile neutropenic cancer patients.
Inova Fairfax Hospital
Falls Church, VA
Co-Investigators: Joseph Gibbons, PharmD; Steven Willis, PharmD;
Leila Mohassel, PharmD, BCOP
2010-2011
Antibiotic selection and duration for urinary tract infections
on hospitalist medicine teaching teams at a community
teaching hospital.
Inova Fairfax Hospital
Falls Church, VA
Co-Investigators: Anne Rain Tanner, PharmD; Alisa Escano, PharmD,
BCPS
2008-2009
Antibiotic consumption and infection rates in intensive care units.
Emory University Hospital Midtown
Atlanta, GA
Co-Investigators: Jesse Jacob, MD; James Steinberg, MD
2006-2007
Correlation of vancomycin exposure and outcomes in adult
patients with methicillin-resistant Staphylococcus aureus
pneumonia.
Wake Forest University Baptist Medical Center
Winston-Salem, NC
Co-Investigators: James Johnson, PharmD, BCPS; John
Williamson, PharmD, BCPS
2004-2005
2004-2005
2002-2004
Analysis of perioperative antimicrobial dosing: a process
improvement intervention for Surgical Infection Prevention
(SIP)
Medical University of South Carolina
Charleston, SC
Co-Investigator: G. Mark Baillie, PharmD, MHA, BCPS
Screening and monitoring for potential metabolic effects
of atypical antipsychotics
Medical University of South Carolina
Charleston, SC
Advisor: Amy Vandenberg, PharmD, BCPP
Correlation of plasma levels of pro-inflammatory cytokines with
CYP1A2, CYP2D6, and CYP3A activity measured by cocktail
phenotyping in HIV positive patients, compared with non-infected
controls
UNC Eshelman School of Pharmacy
Chapel Hill, NC
Advisor: Angela D.M. Kashuba, BS Pharm, PharmD
TEACHING EXPERIENCE
2015-current
Lecturer, ID Elective
UNC Eshelman School of Pharmacy
Chapel Hill, NC
2014-current
Lecturer, ID Fellows Core Curriculum and ID Boot Camp
UNC School of Medicine
Chapel Hill, NC
2013-current
Coordinator and lecturer, ID Therapeutics Module
UNC Eshelman School of Pharmacy
Chapel Hill, NC
2010-2012
Lecturer, ID Therapeutics Module
Virginia Commonwealth University School of Pharmacy
Falls Church, VA
2008
Lecturer, Medical-Surgical Nursing Certification Course
Emory University School of Nursing and Emory Healthcare
Atlanta, GA
2008-2009
Lecturer, ID Fellows Didactic Course
Emory Healthcare and Emory University School of Medicine
Atlanta, GA
2008-2009
Preceptor, Infectious Diseases rotation
Required and elective rotations for 4 PGY-1 residents
Emory University Hospital Midtown
Atlanta, GA
2008-2009
University of Georgia School of Pharmacy Preceptor, Infectious
Diseases and Acute Care rotations
Emory University Hospital Midtown
Atlanta, GA
2004-2005
Preceptor, Pharmacy Experience Units I and II (IPPE)
Medical University of South Carolina School of Pharmacy
Charleston, SC
2002-2003
Laboratory Teaching Assistant
UNC Eshelman School of Pharmacy
Chapel Hill, NC
POSTERS AND PUBLICATIONS
Banoub M, and Marx, AH. Retrospective evaluation of the treatment of vancomycin-resistant
enterococcal bloodstream infections at an academic medical center. Presented at the 49th
Annual Midyear Clinical Meeting of the American Society of Health-System Pharmacists,
Anaheim, CA, December 2014.
Schnur J, Marx A, and Shah M. Evaluation of current antibiotic resistance patterns among local
uropathogens in the outpatient treatment of urinary tract infections. Presented at the 32nd
Annual Eastern States Resident Conference, Hershey, PA, May 2013.
Chen Y and Marx A. Evaluation of linezolid use at Inova Fairfax Hospital. Presented at the
46th Annual Midyear Clinical Meeting of the American Society of Health-System
Pharmacists, New Orleans, LA, December 2011.
Tanner AR and Marx A. Daptomycin utilization for gram-positive infections at a community
teaching hospital. Presented at the 45th Annual Midyear Clinical Meeting of the American
Society of Health- System Pharmacists, Anaheim, CA, December 2010.
Kissling K, Massoud V, and Marx A. Evaluation of tigecycline use in a community teaching
hospital. Presented at the 45th Annual Midyear Clinical Meeting of the American Society of
Health-System Pharmacists, Anaheim, CA, December 2010.
Marx A, Chee J, and Tassone D. Comparison of neonatal bilirubin levels following in utero
exposure to atazanavir versus other antiretroviral agents. Presented at the 50th Interscience
Conference on Antimicrobial Agents and Chemotherapy, Boston, MA, September 2010.
Jacob J, Herring A, and Steinberg J. Antibiotic consumption and infection rates in intensive
care units. Presented at the 19th Annual Scientific Meeting of the Society of Healthcare
Epidemiology of America, San Diego, CA, March 2009.
Herring AR and Williamson JC. Principles of antimicrobial use in older adults. Clin Geriat
Med. 2007;23(3):481-97.
Luther VP, Smith ZE, Varela V, Williamson JC, Karchmer TB, Palavecino E, Herring A,
Marion MC, and Ohl CA. Risk factors for invasive infection due to cephalosporin resistant
Enterobacter spp. Presented at Wake Forest University Baptist Medical Center Resident
Research Day, Winston-Salem, NC, May 2007.
Herring AR, Johnson JE, Ohl CA, and Williamson JC. Correlation of vancomycin exposure
and outcomes in adult patients with methicillin-resistant Staphylococcus aureus pneumonia.
Presented at the 40th Annual American Society of Health-System Pharmacists Midyear
Clinical Meeting, Anaheim, CA, December 2006. Presented at the 37th Annual Southeastern
Residency Conference, Athens, GA, May 2004.
Herring AR and Baillie GM. Analysis of perioperative antimicrobial dosing: a process
improvement intervention for Surgical Infection Prevention (SIP). Presented at the 38th
Annual American Society of Health-System Pharmacists Midyear Clinical Meeting, New
Orleans, LA, December 2004. Presented at the 35th Annual Southeastern Residency
Conference, Athens, GA, May 2004.
INVITED PRESENTATIONS
March 2015
UNC Grand Rounds, ASHP Advantage webcast CE.
Enduring questions about S. aureus disease.
ACPE accredited program.
UNC Medical Center, Chapel Hill, NC.
September 2014
Making Antimicrobials Safer for All
Nursing Continuing Education seminar.
UNC School of Nursing Center for Lifelong Learning.
William and Ida Friday Center, Chapel Hill, NC.
April 2012
Pediatric Grand Rounds: An Update on Vancomycin Dosing and
Monitoring for the Pediatric Clinician.
Accredited Physician CME.
Inova Fairfax Hospital, Falls Church, VA.
March 2011
Update on Urinary Tract Infections.
ACPE accredited continuing education seminar.
Virginia Society of Healthsystems Pharmacists 2011 Spring Seminar.
Arlington, VA
September 2010
September 2011
Pharmacotherapy of Central Nervous System Infections.
Virginia Commonwealth University School of Pharmacy
Falls Church, VA.
January 2009
Pharmacology of Quinolones, Tetracyclines, and Macrolides. Emory
University Physician Assistant Program. Atlanta, GA.
November 2008
Update on New Antimicrobial Agents. A c c r e d i t e d P h y s i c i a n
C M E . 9 t h Annual Southern Hospital Medicine Conference. Atlanta,
GA.
November 2008
A Hospitalist’s Guide to Antifungal Agents. A c c r e d i t e d P h y s i c i a n
C M E . 9th Annual Southern Hospital Medicine Conference. Atlanta,
GA.
July 2008
Aminoglycosides and Vancomycin: A Practical Approach to Dosing
and Monitoring. Emory University Infectious Diseases Fellows’
Didactic Course. Atlanta, GA.
SELECTED PRESENTATIONS
October 2010
Antifungal review for pharmacists. ACPE accredited continuing
education seminar. Inova Fairfax Hospital, Falls Church, VA.
September 2008
Alternative and emerging therapies for treatment of C. difficileassociated diarrhea. Case presentation for PGY-1 residents and
clinical pharmacists. Emory University Hospital Midtown, Atlanta, GA.
August 2008
Antimicrobial use in medical-surgical patients: Focus on Nursing
Care. Emory School of Nursing Medical-Surgical Nursing Certification
Course. Emory University Hospital Midtown, Atlanta, GA.
June 2007
A case-based approach to antifungal agents. ACPE accredited
continuing education seminar. Wake Forest Baptist Medical Center,
Winston-Salem, NC.
March 2007
Febrile neutropenia: what to do after antibacterial therapy fails.
Lecture for Hematology/Oncology elective course. Campbell
University School of Pharmacy, Buies Creek, NC.
December 2006
Achieving antimicrobial synergy against methicillin-resistant
Staphylococcus aureus. Department of Pharmacy Case Conference.
Wake Forest University Baptist Medical Center, Winston-Salem, NC.
August 2006
Antiviral agents. Infectious Diseases Fellows’ Conference. Wake
Forest
University Baptist Medical Center, Winston-Salem, NC.
April 2005
Pharmacologic strategies for the prevention of radiocontrast-induced
nephropathy. ACPE accredited continuing education seminar.
Medical University of South Carolina, Charleston, SC.
PROFESSIONAL AFFILIATIONS
2006-current
Society of Infectious Diseases Pharmacists, member
2010, Programming Committee member
2006-current
American Society for Microbiology, member
2004-current
American College of Clinical Pharmacy, member
AWARDS AND HONORS
2008
Emory Healthcare Clinical Certification Award
2002-2004
Howard Q. and Mescal S. Ferguson Scholar
2002
Phi Lambda Sigma Pharmaceutical Leadership Society
2002
Rho Chi Pharmaceutical Honor Society
2001-2002
Thomas G. Cornwell Scholar
1999-2004
University of North Carolina School of Pharmacy Honors Program
1998
Phi Beta Kappa